• Home
  • 2021 Fall Meeting REGISTER TO ATTEND

2021 Fall Meeting REGISTER TO ATTEND

  • 22 Oct 2021
  • 8:00 AM - 4:00 PM
  • VIRTUAL- at your computer, tablet, cell phone

Registration

  • Active SCACM Member (2021 dues previously paid) given full access to Symposium lectures and Exhibits plus access to recordings of these educational materials at NO ADDITIONAL CHARGE.
  • Payment of this fee gives registrant an Active 2021 SCACM 1-Year Membership and full access to Symposium lectures and Exhibits plus access to recordings of these educational materials at NO ADDITIONAL CHARGE.
  • IMPORTANT: Obtain the Registration Code from KPHL BEFORE you select this option. The KY Public Health Lab (KPHL) is sponsoring attendance for those who live or work in KY. Payment of this fee by KPHL gives registrant an Active 2021 SCACM 1-Year Membership and full access to Symposium lectures and Exhibits plus access to recordings of these educational materials at NO ADDITIONAL CHARGE.

Registration is closed


NOTE:  As the speakers share them, the HANDOUTS will be available HERE.


Register using the  button to your left 

Preliminary Program Details:

SCACM is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.®  Program.

ALL TIMES LISTED ARE IN EASTERN STANDARD TIME

8:00 – 8:19 AM Become familiar with navigating your virtual site and prepare your device(s)

8:20 – 9:20 AM 1.0 Contact Hour - Level: Basic - P.A.C.E. ® # 362-401-21

COVID-19 and Beyond: Selection and Repurposing of SARS-CoV-2 Testing Platforms

This session will focus on repurposing SARS-CoV-2 assay platforms for non-SARS-CoV-2 testing. Important considerations for shifting testing will be discussed as well as highlighting ways to repurpose SARS-CoV-2 assays.

Paige M.K. Larkin, PhD, D(ABMM), M(ASCP)CM

Director of Molecular Microbiology, NorthShore University HealthSystem, Evanston, Illinois
Clinical Assistant Professor, Pritzker School of Medicine, University of Chicago, Chicago, Illinois

Objectives: At the conclusion of the lecture, participants will be able to,

  1. Become familiar with SARS-CoV-2 assays and availability of non-SARS-CoV-2 assays for those platforms
  2. Recognize ways to repurpose SARS-CoV-2 testing platforms
  3. Discuss factors that should be considered when deciding whether to shift from SARS-CoV-2 testing to non-SARS-CoV-2 testing on a platform

9:25 – 10:00 AM Break and Visit the Vendors

10:05 –11:05 AM 1.0 Contact Hour - Level: Basic - P.A.C.E. ® # 362-402-21

Detecting the Spread of Candida auris Across the Midwest

Since it first emerged, Candida auris has surprised the clinical community with its high rate of drug resistance and ability to resist clearance. Diagnostic methods are becoming increasingly more reliable and accessible for clinical labs. As this yeast spreads development of detection protocols and screening strategies is becoming necessary for more and more labs.

Alana Sterkel, PhD, D(ABMM), SM(ASCP)CM

Associate Director, Communicable Disease Division, Wisconsin State Laboratory of Hygiene, Madison, Wisconsin
Assistant Professor, Department of Pathology and Laboratory Medicine, School of Medicine and Public Health, University of WI, Madison, Wisconsin

Objectives: At the conclusion of the lecture, participants will be able to,

  1. Describe the emergence and spread of C. auris
  2. Plan for appropriate safety measures when handling C. auris
  3. Develop diagnostic strategies for detecting C. auris

11:10 AM –12:10 PM 1.0 Contact Hour - Level: Intermediate - P.A.C.E. ® # 362-403-21

Have COVID-19 Changes Made Healthcare More or Less Safe From Infection?

The COVID-19 pandemic resulted in changes in the way we do things in healthcare. Some changes improved healthcare and kept patients and staff safer. The pandemic also revealed deficiencies in our healthcare systems. Some changes will be discontinued when the pandemic recedes and some will become permanent. This session will look at the effect of the pandemic on the risks of infectious diseases in the community and the healthcare system.

Richard A. Van Enk, Ph.D., FSHEA, CIC

Director, Infection Prevention and Epidemiology, Bronson Health Care, Kalamazoo, Michigan
Clinical Associate Professor, Department of Biomedical Sciences, Homer Stryker M.D. School of Medicine, Western Michigan University, Kalamazoo, Michigan

Objectives: At the conclusion of the lecture, participants will be able to,

  1. List the most common changes in healthcare resulting from the COVID-19 pandemic, focusing on those recommended by the CDC
  2. Describe at least three infections whose risk and rates may have been altered by COVID-19
  3. List at least three things we learned, will continue, or will stop doing, to reduce the risk of infection as a result of COVID-19

12:15 – 1:05 PM Lunch and Visit the Vendors

1:10 – 2:10 PM 1.0 Contact Hour - Level: Intermediate - P.A.C.E. ® # 362-404-21

So You Have a Discrepant Genotypic and Phenotypic AST Result, What Now?

This session will provide case examples of discrepancies between phenotypic and genotypic antimicrobial susceptibility results and the approaches to resolving the discrepancies.

Jennifer Dien Bard, PhD, D(ABMM)

Director of Microbiology and Virology, Children’s Hospital Los Angeles, Los Angeles, California
Associate Professor, Department of Pathology, Keck School of Medicine, University of Southern California, Los Angeles, California

Objectives: At the conclusion of the lecture, participants will be able to,

  1. Summarize the benefits and limitations of phenotypic and genotypic AST
  2. Compare the performance of phenotypic and genotypic AST
  3. Describe examples of discrepancies between phenotypic and genotypic AST and potential resolutions

2:15 – 2:40 PM Lunch and Visit the Vendors

2:45 – 3:35 PM 1.0 Contact Hour - Level: Intermediate - P.A.C.E. ® # 362-405-21

Updates in Diagnostics for Detection, Identification and Determination of Resistance in Mycobacteria

This session will provide updates of the identification and resistance detection of Mycobacteria and discuss the limitations of the tests. She will also provide insights into new testing that is in development.

Nicole Parrish, PhD, D(ABMM)

Director of Mycobacteriology, Johns Hopkins Hospital, Baltimore, MD
Associate Professor, Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD

Objectives: At the conclusion of the lecture, participants will be able to,

  • Understand current laboratory algorithms in clinical mycobacteriology

  • Understand limitations of current tests and alternatives.

  • Be aware of new diagnostics that are in development

3:35 – 4:00 PM Evaluation Collections, Thanks, Conclusion

Frequently Asked Questions:


Powered by Wild Apricot Membership Software